Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 277 clinical trials
Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC

This is a two-group, parallel, randomized, standard-control phase II study comparing the safety and efficacy of trifluridine/tipiracil combined with oxaliplatin and bevacizumab versus XELOX plus

  • 0 views
  • 03 Nov, 2021
  • 1 location
Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer

A recent study at the Department of Oncology, Vejle Hospital (NCT02399592), investigated bevacizumab and tocotrienol in ovarian cancer patients and concurrently monitored the level of methylated

  • 0 views
  • 07 May, 2021
  • 1 location
Two Chemotherapy Regimens Plus or Minus Bevacizumab

the treatment of well differentiated pancreatic neuroendocrine tumors alone or in combination with bevacizumab (beva) on progression-free survival (PFS) and compare the chemotherapy regimens alone or

capecitabine
bevacizumab
neutrophil count
pancreatic neuroendocrine tumor
metastasis
  • 0 views
  • 23 Jan, 2021
  • 1 location
Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer

This double blind, randomized phase II trial will investigate whether the addition of tocotrienol will improve the effect and lower the toxicity of standard chemotherapy and bevacizumab. Half of

neutrophil count
kidney function tests
hysterectomy
oxaliplatin
platelet count
  • 0 views
  • 02 Dec, 2021
  • 1 location
Alectinib in Combination With Bevacizumab in ALK Positive NSCLC

to explore therapeutic combinations which might derive in greater long-term survival for this patient subgroup. Although encouraging data has been reported in terms of adding Bevacizumab to EGFR-TKIs

  • 0 views
  • 18 Feb, 2021
  • 1 location
A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

This research study is evaluating three drugs called Nivolumab, Bevacizumab, and Rucaparib as a possible treatment for relapsed Relapsed Ovarian, Fallopian Tube Or Peritoneal Cancer.

chemotherapy regimen
direct bilirubin
endocrine therapy
carcinoma in situ
hormone therapy
  • 0 views
  • 06 Dec, 2021
  • 3 locations
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial cancer. Safety and futility of this drug combination will be assessed to see what effect this treatment has on this patient population.

carcinoma
maintenance therapy
adenocarcinoma
bevacizumab
measurable disease
  • 40 views
  • 20 Sep, 2021
  • 3 locations
Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT

To prospect studying the efficacy and safety of treating NVG with the intracameral versus the intravitreal injection of Bevacizumab.

  • 11 views
  • 24 Jan, 2021
  • 1 location
First Line Atezolizumab Paclitaxel and Bevacizumab (Avastin ) in mTNBC

This is a multicenter, open-label, single-arm, phase II clinical trial to evaluate to evaluate the efficacy and safety of first line atezolizumab in combination with paclitaxel and bevacizumab

  • 0 views
  • 27 Jan, 2021
  • 20 locations
Atezolizumab Plus Bevacizumab With HCC and HBV Infection

This is a single-arm clinical trial. The main objective is to determine the efficacy of atezolizumab+bevacizumab therapy in patients with advanced hepatocellular carcinoma and with chronic

  • 0 views
  • 04 Apr, 2021
  • 8 locations